Home
>
National Drug Code (NDC)
>
Clozapine
Clozapine - 0093-3011-01 - (clozapine)
Drug Information of Clozapine
| Product NDC: | 0093-3011 |
| Proprietary Name: | Clozapine |
| Non Proprietary Name: | clozapine |
| Active Ingredient(s): | 12.5 mg/1 & nbsp; clozapine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clozapine
| Product NDC: | 0093-3011 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021590 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20120830 |
Package Information of Clozapine
| Package NDC: | 0093-3011-01 |
| Package Description: | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0093-3011-01) |
NDC Information of Clozapine
| NDC Code | 0093-3011-01 |
| Proprietary Name | Clozapine |
| Package Description | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0093-3011-01) |
| Product NDC | 0093-3011 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clozapine |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20120830 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | CLOZAPINE |
| Strength Number | 12.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |
